Reuters: Health
The U.S. Food and Drug Administration has declined to approve Correvio Pharma Corp's drug to correct irregular rhythm in the upper chambers of the heart, the company said on Tuesday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment